Terms: = Skin cancer AND PRRX1, ENSG00000116132, 5396
6 results:
1.
Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
Front Immunol; 2022; 13():754645. PubMed ID: 35281030
[TBL] [Abstract] [Full Text] [Related]
2. Tumor suppressive microRNA-485-5p targets prrx1 in human skin melanoma cells, regulating epithelial-mesenchymal transition and apoptosis.
Wu X; Bao H
Cell Biol Int; 2021 Jul; 45(7):1404-1414. PubMed ID: 33620119
[TBL] [Abstract] [Full Text] [Related]
3. Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing
Klover PJ; Thangapazham RL; Kato J; Wang JA; Anderson SA; Hoffmann V; Steagall WK; Li S; McCart E; Nathan N; Bernstock JD; Wilkerson MD; Dalgard CL; Moss J; Darling TN
Elife; 2017 Jul; 6():. PubMed ID: 28695825
[TBL] [Abstract] [Full Text] [Related]
4. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.
Palla AR; Piazzolla D; Alcazar N; Cañamero M; Graña O; Gómez-López G; Dominguez O; Dueñas M; Paramio JM; Serrano M
Sci Rep; 2015 May; 5():10205. PubMed ID: 25988972
[TBL] [Abstract] [Full Text] [Related]
5. Age standardized incidence rates of oral cancer in South Africa, 1988-1991.
Hille JJ; Shear M; Sitas F
J Dent Assoc S Afr; 1996 Dec; 51(12):771-6. PubMed ID: 9462036
[TBL] [Abstract] [Full Text] [Related]
6. Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure.
Fears TR; Scotto J
Cancer Invest; 1983; 1(2):119-26. PubMed ID: 6667401
[TBL] [Abstract] [Full Text] [Related]
